Supermax Corporation Share Price

Equities

SUPERMX

MYL7106OO007

Medical Equipment, Supplies & Distribution

End-of-day quote BURSA MALAYSIA 23:00:00 14/05/2024 BST 5-day change 1st Jan Change
1.08 MYR +24.86% Intraday chart for Supermax Corporation +23.43% +14.89%

Financials

Sales 2024 * 1.03B 220M 17.38B Sales 2025 * 1.29B 275M 21.7B Capitalization 2.77B 592M 46.72B
Net income 2024 * -4M -855K -67.45M Net income 2025 * 56M 11.97M 944M EV / Sales 2024 * 2.69 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 2.15 x
P/E ratio 2024 *
108 x
P/E ratio 2025 *
36 x
Employees -
Yield 2024 *
0.43%
Yield 2025 *
0.85%
Free-Float 55.97%
More Fundamentals * Assessed data
Dynamic Chart
Supermax Buys Out Supermax Healthcare Canada for C$5.5 Million MT
Supermax Corporation Berhad entered into a Share Sale Agreement to acquire remaining 33% stake in Supermax Healthcare Canada Inc. from Sylvain Bergeron for CAD 5.5 million. CI
Supermax Corporation Berhad Announces Resignation of Yap Lang Ling as Independent and Non Executive Chairman of Risk Committee CI
Supermax Corporation Berhad Announces Resignation of Dr. Yap Lang Ling as Independent and Non Executive Director CI
Supermax Buys Back Shares MT
Supermax Corporation Berhad Announces Audit Committee Changes, Effective May 8, 2024 CI
Supermax Corporation Berhad Announces Re-Designation of Wong Phait Lee from Non Executive Director to Executive Director, Effective May 8, 2024 CI
Supermax Buys Back Shares MT
Supermax Buys Back Shares MT
Supermax Corporation Berhad commences an Equity Buyback Plan, under the authorization approved on December 8, 2023. CI
Supermax Corporation Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Supermax Names CEO, COO MT
Supermax Corporation Berhad Appoints Yip Kit Weng as Independent and Non Executive Member of Risk Committee, Effective January 2, 2024 CI
Supermax Corporation Berhad Appoints Yap Lang Ling as Independent and Non Executive Chairman of Risk Committee, Effective January 2, 2024 CI
Supermax Corporation Berhad Announces Resignation of Albert Saychuan Cheok, as Independent and Non Executive Member of Risk Committee, Effective 02 Jan 2024 CI
More news
1 day+24.86%
1 week+23.43%
Current month+27.06%
1 month+33.33%
3 months+19.34%
6 months+25.58%
Current year+14.89%
More quotes
1 week
0.87
Extreme 0.865
1.09
1 month
0.79
Extreme 0.79
1.09
Current year
0.79
Extreme 0.79
1.09
1 year
0.76
Extreme 0.755
1.09
3 years
0.64
Extreme 0.64
5.10
5 years
0.64
Extreme 0.64
12.22
10 years
0.40
Extreme 0.395
12.22
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 01/01/18
Founder 64 31/12/86
Corporate Secretary - 31/07/23
Members of the board TitleAgeSince
Founder 64 31/12/86
Chairman 74 18/10/18
Director/Board Member 61 01-01
More insiders
Date Price Change Volume
15/05/24 1.08 +24.86% 325,313,100
14/05/24 0.865 -2.81% 9,122,600
13/05/24 0.89 0.00% 15,793,900
10/05/24 0.89 +2.30% 16,089,500
09/05/24 0.87 -0.57% 5,149,200

End-of-day quote BURSA MALAYSIA, May 14, 2024

More quotes
Supermax Corporation Berhad is an investment holding company, engaged in the production of rubber gloves. The Company operates through four segments: Investment holding, Manufacturing of gloves, Trading of gloves and Others. The Company is an international manufacturer, distributor, and marketer of medical gloves. It manufactures various types of nitrile latex and natural rubber gloves, which are exported to over 165 countries around the world, such as the United States of America, European Union, Middle East, Asia, and South Pacific countries. The Company owns a range of brands, such as Supermax, Aurelia and Maxter, which are used by laboratories, hospitals, pharmacists, doctors, and surgeons throughout the world. It produces over 26 billion pieces of gloves per year. It has approximately eight distribution centres based in the United States of America, Brazil, Canada, Germany, Hong Kong, and United Kingdom.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
1.08 MYR
Average target price
0.9633 MYR
Spread / Average Target
-10.80%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SUPERMX Stock